Rachel Lynn Salzman

Founder at SwanBio Therapeutics, Inc.

65 year

Health Technology

Network origin in Rachel Lynn Salzman first degree

Entity	Entity type	Industry
SwanBio Therapeutics, Inc. SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. 8	Holding Company	Biotechnology	8

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Rachel Lynn Salzman via their personal network

Company	Sector	Related people	Main position
Alkermes, Inc. Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.	Pharmaceuticals: Major	Patricia Allen	Director of Finance/CFO
AMGEN INC.	Pharmaceuticals: Major	John Tsai	Chief Tech/Sci/R&D Officer
BRISTOL-MYERS SQUIBB COMPANY	Pharmaceuticals: Major	John Tsai	Private Equity Investor
Washington University in St. Louis	College/University	John Tsai	Undergraduate Degree
CUBIST PHARMACEUTICALS INC	Pharmaceuticals: Major	Alison Lawton	Director/Board Member
MERCK KGAA	Pharmaceuticals: Major	Danny Bar-Zohar	Chief Tech/Sci/R&D Officer
ACADIA PHARMACEUTICALS INC.	Pharmaceuticals: Major	David Weiner	Corporate Officer/Principal
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Medical Specialties	Alison Lawton	Corporate Officer/Principal
ATYR PHARMA, INC.	Pharmaceuticals: Major	David Weiner	Chief Tech/Sci/R&D Officer
REGENXBIO INC.	Pharmaceuticals: Major	Karen F. Kozarsky	Chief Tech/Sci/R&D Officer
NOVARTIS AG	Pharmaceuticals: Major	John Tsai	Chief Tech/Sci/R&D Officer
University of Pennsylvania	College/University	Karen F. Kozarsky	Corporate Officer/Principal
University of Oxford	College/University	Alex Hamilton	Graduate Degree
University of Cambridge	College/University	Alex Hamilton	Doctorate Degree
ALNYLAM PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Patricia Allen	Director of Finance/CFO
Amherst College	College/University	Karen F. Kozarsky	Undergraduate Degree
Massachusetts Institute of Technology	College/University	Karen F. Kozarsky	Doctorate Degree
Brandeis University	College/University	David Weiner	Undergraduate Degree
Colgate University	College/University	Christopher Brooke	Undergraduate Degree
University of California San Diego	College/University	David Weiner	Corporate Officer/Principal
University of Vermont	College/University	David Weiner	Corporate Officer/Principal
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Pharmaceuticals: Major	David Weiner	Corporate Officer/Principal
Winchester College	College/University	Alex Hamilton	Undergraduate Degree
Novartis Institute for Functional Genomics, Inc. Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA.	Miscellaneous Commercial Services	John Tsai	Director/Board Member
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major	Danny Bar-Zohar	Chief Tech/Sci/R&D Officer
GlaxoSmithKline LLC GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.	Pharmaceuticals: Major	Karen F. Kozarsky	Corporate Officer/Principal
VERASTEM, INC.	Biotechnology	Alison Lawton	Director/Board Member
BLUEPRINT MEDICINES CORPORATION	Biotechnology	John Tsai	Director/Board Member
Lumos Pharma Sub, Inc. Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.	Medical/Nursing Services	David Weiner	Chief Tech/Sci/R&D Officer
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.	Investment Managers	John Tsai Alex Hamilton Danny Bar-Zohar	Private Equity Investor Private Equity Investor Private Equity Investor
The Wharton School of the University of Pennsylvania	College/University	Christopher Brooke	Masters Business Admin
Anokion SA Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland.	Medical/Nursing Services	Patricia Allen	Director/Board Member
Sackler School of Medicine	College/University	Danny Bar-Zohar	Doctorate Degree
University of Louisville School of Medicine	College/University	John Tsai	Doctorate Degree
Kanyos Bio, Inc. Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA.	Pharmaceuticals: Major	Patricia Allen	Director/Board Member
Yumanity, Inc. Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA.	Pharmaceuticals: Major	Patricia Allen	Director/Board Member
Vividion Therapeutics, Inc. Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.	Miscellaneous Commercial Services	Patricia Allen	Director of Finance/CFO
Inversago Pharma, Inc. Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada.	Pharmaceuticals: Major	Patricia Allen	Director/Board Member
Anaveon AG Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland.	Biotechnology	Alex Hamilton	Director/Board Member
AxoSim, Inc. AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA.	Packaged Software	David Weiner	Chairman
BRIGHT MINDS BIOSCIENCES INC.	Biotechnology	David Weiner	Director/Board Member
CHEMOMAB THERAPEUTICS LTD.	Biotechnology	David Weiner	Chief Tech/Sci/R&D Officer
Forcefield Therapeutics Ltd.		John Tsai	Chief Executive Officer
UB School of Medicine & Biomedical Sciences	College/University	David Weiner	Doctorate Degree
AYTU BIOPHARMA, INC.	Pharmaceuticals: Major	Christopher Brooke	Chief Operating Officer